These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25119130)

  • 1. Extensively drug-resistant Pseudomonas aeruginosa bacteremia in solid organ transplant recipients.
    Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; González-Costello J; Cruzado JM; Carratalà J
    Transplantation; 2015 Mar; 99(3):616-22. PubMed ID: 25119130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in solid-organ transplant recipients.
    Bodro M; Sabé N; Tubau F; Lladó L; Baliellas C; Roca J; Cruzado JM; Carratalà J
    Transplantation; 2013 Nov; 96(9):843-9. PubMed ID: 23883973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pseudomonas aeruginosa bacteremia over a 10-year period: multidrug resistance and outcomes in transplant recipients.
    Johnson LE; D'Agata EM; Paterson DL; Clarke L; Qureshi ZA; Potoski BA; Peleg AY
    Transpl Infect Dis; 2009 Jun; 11(3):227-34. PubMed ID: 19302282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency and clinical outcomes of ESKAPE bacteremia in solid organ transplantation and the risk factors for mortality.
    Ye QF; Zhao J; Wan QQ; Qiao BB; Zhou JD
    Transpl Infect Dis; 2014 Oct; 16(5):767-74. PubMed ID: 25124187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors, clinical characteristics, and outcomes of invasive fungal infections in solid organ transplant recipients.
    Bodro M; Sabé N; Gomila A; Ayats J; Baliellas C; Roca J; Melilli E; Carratalà J
    Transplant Proc; 2012 Nov; 44(9):2682-5. PubMed ID: 23146493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factors for mortality and septic shock in liver transplant recipients with ESKAPE bacteremia.
    Ouyang W; Li X; Wan Q; Ye Q
    Hepatogastroenterology; 2015; 62(138):346-9. PubMed ID: 25916061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A five-year review of Pseudomonas aeruginosa bacteremia in children hospitalized at a single center in southern China.
    Zhang Q; Smith JC; Zhu Q; Guo Z; MacDonald NE
    Int J Infect Dis; 2012 Aug; 16(8):e628-32. PubMed ID: 22709682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of shock and mortality in solid organ transplant recipients with bacteremia caused by non-lactose-fermenting gram-negative bacilli.
    Wan Q; Luo A; Ye Q; Liu S; Zhou J
    Infect Dis (Lond); 2016; 48(1):32-9. PubMed ID: 26329287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter case-case control study for risk factors and outcomes of extensively drug-resistant Acinetobacter baumannii bacteremia.
    Ng TM; Teng CB; Lye DC; Apisarnthanarak A
    Infect Control Hosp Epidemiol; 2014 Jan; 35(1):49-55. PubMed ID: 24334798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
    Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
    Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute Inflammatory Response of Patients with Pseudomonas aeruginosa Infections: A Prospective Study.
    Gómez-Zorrilla S; Morandeira F; Castro MJ; Tubau F; Periche E; Cañizares R; Dominguez MA; Ariza J; Peña C
    Microb Drug Resist; 2017 Jun; 23(4):523-530. PubMed ID: 27754817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of extensively drug-resistant gram-negative bacteremia among solid-organ transplant recipients: a multicenter study.
    Yanık Yalçın T; Azap Ö; Köse A; Bayındır Y; Sarıcaoğlu EM; Çınar G; Uygun Kızmaz Y; Kurşun E; Alışkan HE; Tezer Tekçe Y; Eren Kutsoylu OÖ; Egeli T; Arı A; Albayrak Y; Çabadak H; Deniz S; Demir Önder K; Kızılateş F; Özger S; Güzel Tunçcan Ö; Haberal M
    Turk J Med Sci; 2021 Aug; 51(4):1960-1968. PubMed ID: 33865241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emergence of highly antibiotic-resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment.
    Philippe E; Weiss M; Shultz JM; Yeomans F; Ehrenkranz NJ
    Clin Perform Qual Health Care; 1999; 7(2):83-7. PubMed ID: 10747571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy.
    Schechner V; Gottesman T; Schwartz O; Korem M; Maor Y; Rahav G; Karplus R; Lazarovitch T; Braun E; Finkelstein R; Lachish T; Wiener-Well Y; Alon D; Chowers M; Bardenstein R; Zimhony O; Paz A; Potasman I; Giladi M; Schwaber MJ; Klarfeld-Lidji S; Hochman M; Marchaim D; Carmeli Y
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):38-45. PubMed ID: 21763093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical characteristics and risk factors for mortality in cefepime-resistant Pseudomonas aeruginosa bacteremia.
    Su TY; Ye JJ; Hsu PC; Wu HF; Chia JH; Lee MH
    J Microbiol Immunol Infect; 2015 Apr; 48(2):175-82. PubMed ID: 24064286
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Herrera S; Morata L; Sempere A; Verdejo M; Del Rio A; Martínez JA; Cuervo G; Hernández-Meneses M; Chumbita M; Pitart C; Puerta P; Monzó P; Lopera C; Aiello F; Mendoza S; Garcia-Vidal C; Soriano A; Bodro M
    Antibiotics (Basel); 2023 Feb; 12(2):. PubMed ID: 36830291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extensively drug-resistant Pseudomonas aeruginosa: risk of bloodstream infection in hospitalized patients.
    Peña C; Gómez-Zorrilla S; Suarez C; Dominguez MA; Tubau F; Arch O; Oliver A; Pujol M; Ariza J
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2791-7. PubMed ID: 22552893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy.
    Tuon FF; Gortz LW; Rocha JL
    Braz J Infect Dis; 2012; 16(4):351-6. PubMed ID: 22846123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing trends in the aetiology, treatment and outcomes of bloodstream infection occurring in the first year after solid organ transplantation: a single-centre prospective cohort study.
    Oriol I; Sabé N; Simonetti AF; Lladó L; Manonelles A; González J; Tubau F; Carratalà J
    Transpl Int; 2017 Sep; 30(9):903-913. PubMed ID: 28500792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Staphylococcus aureus bacteremia in solid organ transplant recipients: evidence for improved survival when compared with nontransplant patients.
    Malinis MF; Mawhorter SD; Jain A; Shrestha NK; Avery RK; van Duin D
    Transplantation; 2012 May; 93(10):1045-50. PubMed ID: 22357175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.